Updated product information for healthcare professionals and patients regarding the small risk of severe acute pancreatitis in patients taking GLP-1s.
Similar Posts
Medicines and Medical Devices Act 2021 – Stakeholder survey
We invite feedback on the operation and impact of the human medicines and medical devices legislation as part of a statutory review required under the Medicines and Medical Devices Act 2021.
Corporate report: MHRA: policy for handling corporate conflicts of interest
Information about how we handle potential corporate conflicts of interest (COI) between different parts of the Agency.
Field Safety Notices: 5 to 9 May 2025
List of Field Safety Notices from 5 to 9 May 2025.
MHRA outlines intent to speed up patient access to innovative medical devices
Statement of Policy Intent sets out initial thinking on a new Early Access service to help patients benefit sooner from innovative medical devices that address unmet clinical needs.
Field Safety Notices: 3 to 7 November 2025
List of Field Safety Notices from 3 to 7 November 2025.
Guidance: International Recognition Procedure
How to use the procedure for medicines licensing applications.